Go Deep
Choksi Laboratories Limited
Choksi Laboratories Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Sep 2026 | 20,232 | 60.8 | 5.18 | 1.34 | 189.85 |
| Sep 2026 | 19,814 | 64.0 | 5.43 | 1.34 | 198.90 |
| Sep 2026 | 20,357 | 60.0 | 5.10 | 1.34 | 187.30 |
| Sep 2026 | 20,357 | 60.0 | 5.10 | 1.34 | 187.30 |
| Sep 2026 | 20,357 | 60.0 | 5.10 | 1.34 | 187.30 |
| Sep 2026 | 20,283 | 60.7 | 5.14 | 1.34 | 188.90 |
| Oct 2026 | 19,033 | 58.1 | 4.93 | 1.34 | 181.20 |
| Oct 2026 | 18,141 | 61.8 | 5.24 | 1.34 | 192.35 |
Choksi Laboratories Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 120,629,000.0 | 128,222,000.0 | 108,247,000.0 | 111,171,000.0 |
| Net Profit | 5,824,000.0 | 10,268,000.0 | 3,104,000.0 | 2,421,000.0 |
| EPS | 0.8 | 1.5 | 0.5 | 0.3 |
Choksi Laboratories Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 460,059,000.0 | 417,823,000.0 | 366,951,000.0 | 344,405,000.0 | — |
| Net Profit | 19,643,000.0 | 15,233,000.0 | 11,098,000.0 | 32,100,000.0 | — |
| EPS | 2.8 | 2.2 | 1.6 | 4.6 | — |
Choksi Laboratories Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 719,208,000.0 | 653,321,000.0 | 619,523,000.0 | 603,648,000.0 | — |
| Total Liabilities | 463,453,000.0 | 417,273,000.0 | 397,418,000.0 | 392,564,000.0 | — |
| Total Equity | 255,755,000.0 | 236,048,000.0 | 222,105,000.0 | 211,084,000.0 | — |
Owes vs Owns
Choksi Laboratories Limited owed ₹0.64 for every ₹1 it owned in Mar 2026, down from ₹0.65 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.64× | 0.64× | 0.64× | 0.65× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Choksi Laboratories Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 0.6%Receivables 20.5%Fixed assets (tangible) 71.7%Intangible assets 0.6%Long-term investments 1.1%Other assets 5.3%
How it's funded — Mar 2026
Short-term debt 17.2%Long-term debt 24.8%Payables 7.8%Other liabilities 14.7%Shareholders' equity 35.6%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 0.4 | 0.7 | 1.1 | 0.8 |
| Receivables | 14.7 | 11.3 | 10.4 | 10.7 |
| Inventory | 0.2 | 0.6 | 0.4 | 0.2 |
| Fixed assets (tangible) | 51.5 | 47.1 | 46.1 | 44.7 |
| Intangible assets | 0.4 | 0.5 | 0.4 | 0.4 |
| Long-term investments | 0.8 | 0.8 | 0.5 | 0.3 |
| Other assets | 3.8 | 4.4 | 3.2 | 3.3 |
| Liabilities & equity | ||||
| Short-term debt | 12.4 | 12.8 | 11.3 | 6.7 |
| Long-term debt | 17.8 | 15.2 | 18.0 | 23.6 |
| Payables | 5.6 | 5.4 | 3.9 | 1.8 |
| Other liabilities | 10.6 | 8.2 | 6.5 | 7.1 |
| Shareholders' equity | 25.6 | 23.6 | 22.2 | 21.1 |
| Net tangible assets | 25.2 | 23.1 | 21.9 | 20.7 |
Choksi Laboratories Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 78,648,000.0 | 117,780,000.0 | 115,515,000.0 | 82,538,000.0 | — |
| Investing Activities | -70,747,000.0 | -76,051,000.0 | -66,484,000.0 | -7,084,000.0 | — |
| Financing Activities | -11,958,000.0 | -42,176,000.0 | -45,837,000.0 | -76,149,000.0 | — |